MTOR and neoplasm: These family members are activated by ligand-dependent homo-/heterodimerisation and regulate cellular proliferation and tumour progression via the downstream activation of many commonly used growth factor signalling pathways, such as the RAS/RAF/MEK/ERK and PI3K/AKT/mTOR pathways [187] (Figure 19).